Jazz Pharmaceuticals plc buy Wells Fargo & Company
Start price
13.02.25
/
50%
€130.00
Target price
13.02.26
€163.54
Performance (%)
6.50%
End price
14.02.26
€138.45
Summary
This prediction ended on 14.02.26 with a price of €138.45. With a performance of 6.50%, the BUY prediction by Wells_Fargo___Compan for Jazz Pharmaceuticals plc closed with a slight gain. Wells_Fargo___Compan has a follow-up prediction for Jazz Pharmaceuticals plc where he still thinks Jazz Pharmaceuticals plc is a Buy. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Jazz Pharmaceuticals plc | 10.850% | 10.850% | 17.824% |
| iShares Core DAX® | -1,31 % | -0,78 % | 9,15 % |
| iShares Nasdaq 100 | 1,98 % | -2,04 % | 6,57 % |
| iShares Nikkei 225® | 0,59 % | 6,71 % | 31,58 % |
| iShares S&P 500 | 1,42 % | -0,48 % | 3,62 % |
Comments by Wells_Fargo___Compan for this prediction
In the thread Jazz Pharmaceuticals plc diskutieren
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) was upgraded by analysts at Wells Fargo & Company from an "equal weight" rating to an "overweight" rating. They now have a $170.00 price target on the stock, up previously from $130.00.
Ratings data for JAZZ provided by MarketBeat
In the thread Trading Jazz Pharmaceuticals plc
Die von Wells_Fargo___Compan gewählte maximale Laufzeit wurde überschritten
Current prediction by Wells_Fargo___Compan for Jazz Pharmaceuticals plc
Jazz Pharmaceuticals plc
Start price
Target price
Perf. (%)
€155.95
18.11.25
18.11.25
€202.73
18.11.26
18.11.26
4.49%
02.03.26
02.03.26
Stopped prediction by Wells_Fargo___Compan for Jazz Pharmaceuticals plc
Jazz Pharmaceuticals plc
Start price
Target price
Perf. (%)
€162.75
25.02.26
25.02.26
€212.10
25.02.27
25.02.27
0.12%
02.03.26
02.03.26